Prostate pain syndrome-etiology, epidemiology, and research

Urogenital Pain in Clinical Practice

Volumn , Issue , 2007, Pages 211-221

  Pontari, Michel A ^a   Lebed, Brett ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149468022     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (72)

1. Krieger JN, Nyberg L, Jr., Nickel JC. NIH consensus definition and classification of prostatitis. J Am Med Assoc 1999; 282(3):236-7.
2. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999; 54(2):229-33.
3. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology 1996; 48(5):715-21 (discussion 21-2).
4. Drach GW, Fair WR, Meares EM, Stamey TA. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 1978; 120(2):266.
5. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159(4):1224-8.
6. Nickel JC, Nigro M, Valiquette L, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998; 52:797-802.
7. de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993; 41(4):301-7.
8. Moon TD. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis. Urology 1997; 50:543-7.
9. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol 2002; 168:2467-71.
10. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998; 51:578-84.
11. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001; 165:842-5.
12. Rizzo M, Marchetti F, Travaglini F, Trinchieri A, Nickel JC. Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study. World J Urol 2005; 23(1):61-6.
13. Ku JH, Kim ME, Lee NK, Park YH. Influence of environmental factors on chronic prostatitis-like symptoms in young men: results of a community-based survey. Urology 2001; 58:853-8.
14. Mehik A, Hellstrom P, Lukkarinen O, Sarpola A, Jarvelin M. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 2000; 86(4):443-8.
15. Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002; 167:1363-6.
16. Schaeffer AJ, Landis JR, Knauss JS, et al. Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes Of Health chronic prostatitis cohort study. J Urol 2002; 168(2):593-8.
17. Mehik A, Hellstrom P, Sarpola A, Lukkarinen O, Jarvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001; 88(1):35-8.
18. Pontari MA, Litwin MS, O'Leary MP, et al. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005; 96:559-65.
19. Ware JE, Kosinski M, Keller SD. A twelve item short form health survey-construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34:220-3.
20. McNaughton Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001; 16(10):656-62.
21. True LD, Berger RE, Rothman I, Ross SO, Krieger JN. Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 1999; 162:2014-8.
22. Nickel CJ. Prostatitis syndromes: an update for urologic practice. Can J Urol 2000; 7(5):1091-8.
23. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992; 327(5):293-301 (see comment).
24. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991; 19(Suppl. 3):S119-25.
25. Doble A, Thomas BJ, Walker MM, Harris JR, Witherow RO, Taylor-Robinson D. The role of Chlamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. J Urol 1989; 141(2):332-3.
26. Shoskes DA, Shahed AR. Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome. Tech Urol 2000; 6(3):240-2.
27. Daniels NA, Link CL, Barry MJ, McKinlay JB. Are urinary tract infections associated with prostatitis symptoms: results from the Boston Area Community Health (BACH) survey. J Urol 2005; 173(Suppl. 4):28 (Abstract).
28. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170:818-22.
29. Leskinen MJ, Rantakokko-Jalava K, Manninen R, et al. Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (cPPS) and localized prostate cancer. Prostate 2003; 55(2):105-10.
30. Leskinen MJ, Vainionp R, Syrjnen S, et al. Herpes simplex virus, cytomegalovirus, and papilloma-virus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer. Urology 2003; 61(2):397-401.
31. Lee JC, Muller CH, Rothman I, et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003; 169(2):584-7 (discussion 7-8; see comment).
32. Shahed AR, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000; 21(5):669-75.
33. Schaeffer AJ, Wendel EF, Dunn JK, Grayhack JT. Prevalence and significance of prostatic inflammation. J Urol 1981; 125(2):215-9.
34. Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168(3):1048-53.
35. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004; 174:839-45.
36. Stern JA, Koch AE, Campbell PL, Landis JR, Schaeffer AJ. MΠMA and MCP-1: novel biomarkers for chronic prostatitis. J Urol 2005; 173(Suppl. 4):30 (Abstract).
37. Ludwig M, Vidal A, Diemer T, Pabst W, Failing K, Weidner W. Chronic prostatitis/chronic pelvic pain pyndrome: seminal markers of inflammation. World J Urol 2003; 21(2):82-5.
38. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79(6):469-83.
39. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34(5):391-9.
40. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95(16):9465-70.
41. Shoskes DA, Albakri Q, Thomas K, Cook D. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 2002; 168(1):331-5.
42. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1.
43. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993; 151(12):6853-61.
44. Palapattu GS, Shoskes DA. Resolution of the chronic pelvic pain syndrome after renal transplantation. J Urol 2000; 164(1):127.
45. Buyuktuncer ED, Arisan S, Kiremitci MC, et al. MN-SOD polymorphism in chronic pelvic pain syndrome patients. J Urol 2005; 173(Suppl. 4):31 (Abstract).
46. Ponniah S, Arah I, Alexander RB. PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate 2000; 44(1):49-54.
47. Dunphy EJ, Eickhoff JC, Muller CH, Berger RE, McNeel DG. Identification of antigen-specific IgG in sera from patients with chronic prostatitis. J Clin Immunol 2004; 24(5):492-502.
48. Naslund MJ, Strandberg JD, Coffey DS. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol 1988; 140(5):1049-53.
49. Robinette CL. Sex hormone induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 1988; 12:271-86.
50. Diserio GP, Nowotny E. Experimental autoimmune prostatitis: in vivo induction of the autoimmune response to lymphocytic soluble factors. Alterations at the endocrine metabolism level. Am J Reprod Immunol (Copenhagen) 1998; 39(4):226-34.
51. Diserio GP, Carrizo AE, Pacheco-Rupil B, Nowotny E. Effect of male accessory glands autoaggression on androgenic cytosolic and nuclear receptors of rat prostate. Cell Mol Biol 1992; 38(2):201-7.
52. Nickel JC, Downey J, Pontari MA, Shoskes D, Zeitlin S. Randomized placebo controlled multi-center study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis). BJU Int 2004; 96:559-65.
53. Riley DE, Krieger JN. X Chromosomal short tandem repeat polymorphisms near the phosphoglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta 2002; 1586(1):99-107.
54. Riley DE, Krieger JN. Diverse eukaryotic transcripts suggest short tandem repeats have cellular functions. Biochem Biophys Res Commun 2002; 298(4):581-6.
55. Ishigooka M, Zermann DH, Doggweiler R, Schmidt RA. Similarity of distributions of spinal c-fos and plasma extravasation after acute chemical irritation of the bladder and the prostate. J Urol 2000; 164(5):1751-6.
56. Keith IM, Jin J, Neal D, Jr., Teunissen BD, Moon TD. Cell relationship in a Wistar rat model of spontaneous prostatitis. J Urol 2001; 166(1):323-8.
57. Skaper SD. Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions. Mol Neurobiol 2001; 24(1-3):183-99.
58. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59(4):603-8.
59. Lewin GR, Mendell LM. Nerve growth factor and nociception. Trends Neurosci 1993; 16(9):353-9.
60. Varilek GW, Weinstock JV, Pantazis NJ. Isolated hepatic granulomas from mice infected with Schistosoma mansoni contain nerve growth factor. Infect Immun 1991; 59(12):4443-9.
61. Winter J, Forbes CA, Sternberg J, Lindsay RM. Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin. Neuron 1988; 1(10):973-81.
62. Mazurek N, Weskamp G, Erne P, Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett 1986; 198(2):315-20.
63. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44(3):293-9.
64. Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA. Neurourological insights into the etiology of genitourinary pain in men. J Urol 1999; 161(3):903-8.
65. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE. Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol 2003; 170(3):823-6 (discussion 6-7).
66. Spanos C, Pang X, Ligris K, et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 1997; 157(2):669-72.
67. Keast JR, Kepper ME. Differential regulation of trkA and p75 in noradrenergic pelvic autonomic ganglion cells after deafferentation of their cholinergic neighbours. Eur J Neurosci 2001; 13(2):211-20.
68. Meusburger SM, Keast JR. Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro. Neuroscience 2001; 108(2):331-40.
69. Foreman JC. Peptides and neurogenic inflammation. Br Med Bull 1987; 43(2):386-400.
70. Shelburne CP, Ryan JJ. The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 2001; 179:82-93.
71. Mehik A, Hellstrom P, Nickel JC, et al. The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002; 167:137-40 (see comment).
72. Cho IR, Keener TS, Nghiem HV, Winter T, Krieger JN. Prostate blood flow characteristics in the chronic prostatitis/pelvic pain syndrome. J Urol 2000; 163(4):1130-3.